| Nome |
# |
|
Emotional intelligence, emotion regulation and affectivity in adults seeking treatment for obesity., file e1dcb33a-24f3-7715-e053-1705fe0a6cc9
|
245
|
|
Dapagliflozin and cardiovascular outcomes: anything else to DECLARE?, file e1dcb336-78d5-7715-e053-1705fe0a6cc9
|
206
|
|
The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality, file e1dcb33a-1452-7715-e053-1705fe0a6cc9
|
186
|
|
Adverse events with sodium-glucose co-transporter-2 inhibitors: A global analysis of international spontaneous reporting systems, file e1dcb339-e747-7715-e053-1705fe0a6cc9
|
173
|
|
Glucokinase Regulatory Protein Gene Polymorphism Affects Liver Fibrosis in Non-Alcoholic Fatty Liver Disease, file e1dcb330-df39-7715-e053-1705fe0a6cc9
|
139
|
|
Branched-chain amino acids for people with hepatic encephalopathy, file e1dcb330-e250-7715-e053-1705fe0a6cc9
|
133
|
|
Predicting Frailty Condition in Elderly Using Multidimensional Socioclinical Databases, file e1dcb338-30c3-7715-e053-1705fe0a6cc9
|
123
|
|
Preliminary study about the possible glycemic clinical advantage in using a fixed combination of Berberis aristata and Silybum marianum standardized extracts versus only Berberis aristata in patients with type 2 diabetes., file e1dcb32c-534b-7715-e053-1705fe0a6cc9
|
112
|
|
An internet-based approach for lifestyle changes in patients with NAFLD: Two-year effects on weight loss and surrogate markers, file e1dcb331-8ba8-7715-e053-1705fe0a6cc9
|
101
|
|
PNPLA3 GG genotype and carotid atherosclerosis in patients with non-alcoholic fatty liver disease., file e1dcb32c-534d-7715-e053-1705fe0a6cc9
|
83
|
|
Gallstone disease is associated with more severe liver damagein patients with non-alcoholic fatty liver disease, file e1dcb32c-335a-7715-e053-1705fe0a6cc9
|
82
|
|
Long-term weight loss maintenance for obesity: A multidisciplinary approach, file e1dcb32e-c8b6-7715-e053-1705fe0a6cc9
|
76
|
|
Combination of GLP-1 receptor agonists and behavioural treatment in type 2 diabetes elicits synergistic effects on body weight: A retrospective cohort study, file e1dcb333-9666-7715-e053-1705fe0a6cc9
|
75
|
|
A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe, file e1dcb336-6f2f-7715-e053-1705fe0a6cc9
|
75
|
|
Old subjects with sepsis in the emergency department: Trend analysis of case fatality rate, file e1dcb333-96fa-7715-e053-1705fe0a6cc9
|
74
|
|
Stress Hyperglycemia and Complications Following Traumatic Injuries in Individuals With/Without Diabetes: The Case of Orthopedic Surgery, file e1dcb333-ad9f-7715-e053-1705fe0a6cc9
|
70
|
|
Prevention and Treatment of Sarcopenic Obesity in Women, file e1dcb332-de0d-7715-e053-1705fe0a6cc9
|
68
|
|
AISF position paper on nonalcoholic fatty liver disease (NAFLD): updates and future directions., file e1dcb32f-6fa6-7715-e053-1705fe0a6cc9
|
52
|
|
Moderate Alcohol Intake in Non-Alcoholic Fatty Liver Disease: To Drink or Not to Drink?, file e1dcb333-8519-7715-e053-1705fe0a6cc9
|
50
|
|
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial, file e1dcb337-db42-7715-e053-1705fe0a6cc9
|
48
|
|
Analysis of clinical profiles, deformities, and plantar pressure patterns in diabetic foot syndrome, file e1dcb339-8cba-7715-e053-1705fe0a6cc9
|
48
|
|
Management of Diabetes in Candidates for Liver Transplantation and in Transplant Recipients, file 361d76cf-d29d-4596-b2da-2a24efffe882
|
45
|
|
Weight Loss Expectations and Attrition in Treatment-Seeking Obese Women, file e1dcb32d-0228-7715-e053-1705fe0a6cc9
|
45
|
|
Observational research on sodium glucose co-transporter-2 inhibitors: A real breakthrough?, file e1dcb331-8ba1-7715-e053-1705fe0a6cc9
|
43
|
|
Stress Hyperglycemia and Mortality in Subjects With Diabetes and Sepsis, file e1dcb336-15c8-7715-e053-1705fe0a6cc9
|
39
|
|
Fatty liver in pregnancy: a narrative review of two distinct conditions, file e1dcb334-28e8-7715-e053-1705fe0a6cc9
|
37
|
|
The Role of Psychological Well-Being in Weight Loss: New Insights from a Comprehensive Lifestyle Intervention, file e1dcb339-7912-7715-e053-1705fe0a6cc9
|
36
|
|
DXA-assessed changes in body composition in obese women following two different weight loss programs, file e1dcb330-e2a0-7715-e053-1705fe0a6cc9
|
34
|
|
Nutrition in patients with type 2 diabetes: Present knowledge and remaining challenges, file e1dcb339-6fff-7715-e053-1705fe0a6cc9
|
34
|
|
The effect of neuropathy and diabetes type on multisegment foot kinematics: A cohort study on 70 participants with diabetes, file e1dcb339-8612-7715-e053-1705fe0a6cc9
|
31
|
|
Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO), file e1dcb339-7552-7715-e053-1705fe0a6cc9
|
27
|
|
A randomized, controlled trial of 3.0 mg of liraglutide in weight management, file e1dcb32d-1382-7715-e053-1705fe0a6cc9
|
26
|
|
Longstanding underweight eating disorder: associated features and treatment outcome., file e1dcb32c-4388-7715-e053-1705fe0a6cc9
|
20
|
|
Psychological profile and quality of life of morbid obese patients attending a cognitive behavioural program, file e1dcb32b-e1c9-7715-e053-1705fe0a6cc9
|
19
|
|
Physical activity for the prevention and treatment of metabolic disorders., file e1dcb32c-5350-7715-e053-1705fe0a6cc9
|
19
|
|
Effects of antidiabetic agents on steatosis and fibrosis biomarkers in type 2 diabetes: A real-world data analysis, file e1dcb337-ba8e-7715-e053-1705fe0a6cc9
|
18
|
|
Prevalence of Sexual Dysfunction among Postmenopausal Women with and without Metabolic Syndrome., file e1dcb32d-384d-7715-e053-1705fe0a6cc9
|
17
|
|
Dysfunctional eating in type 2 diabetes mellitus: A multicenter Italian study of socio-demographic and clinical associations, file e1dcb333-9668-7715-e053-1705fe0a6cc9
|
17
|
|
Combination of GLP-1 receptor agonists and behavioural treatment in type 2 diabetes elicits synergistic effects on body weight: A retrospective cohort study, file e1dcb335-9e97-7715-e053-1705fe0a6cc9
|
17
|
|
Antiplatelet therapy and the outcome of subjects with intracranial injury: the Italian SIMEU study, file e1dcb32c-43b6-7715-e053-1705fe0a6cc9
|
16
|
|
Motivational interviewing adapted to group setting for the treatment of relapse in the behavioral therapy of obesity. A clinical audit, file e1dcb336-7aea-7715-e053-1705fe0a6cc9
|
16
|
|
Management of non-alcoholic fatty liver disease, file e1dcb337-ba04-7715-e053-1705fe0a6cc9
|
13
|
|
Lifestyle Intervention in NAFLD: Long-Term Diabetes Incidence in Subjects Treated by Web- and Group-Based Programs, file c51f422a-749a-411f-a2f2-1e2fbf693744
|
12
|
|
Cardiovascular, Ocular and Bone Adverse Reactions Associated with Thiazolidinediones: A Disproportionality Analysis of the US FDA Adverse Event Reporting System Database., file e1dcb32b-be51-7715-e053-1705fe0a6cc9
|
11
|
|
Health and ageing: a cross-sectional study of body composition, file e1dcb32b-f777-7715-e053-1705fe0a6cc9
|
10
|
|
Sexuality and psychopathological aspects in premenopausal women with metabolic syndrome., file e1dcb32d-3a1c-7715-e053-1705fe0a6cc9
|
9
|
|
Does the liver accelerate ageing: Talking muscles and liver?, file e1dcb330-a1dc-7715-e053-1705fe0a6cc9
|
9
|
|
Impaired Lipid Profile is a Risk Factor for the Development of Sexual Dysfunction in Women, file e1dcb32f-9b52-7715-e053-1705fe0a6cc9
|
8
|
|
Long-term follow-up of web-based and group-based behavioural intervention in NAFLD in a real world clinical setting, file 538227ca-7ee9-4e71-84b4-6ac6816b3cfd
|
7
|
|
Effects of antidiabetic agents on steatosis and fibrosis biomarkers in type 2 diabetes: A real-world data analysis, file 6fcca37f-3c6c-4dda-873c-ab652592729a
|
7
|
|
Personality features of obese women in relation to binge eating and night eating., file e1dcb32c-4acb-7715-e053-1705fe0a6cc9
|
7
|
|
Diabetes and NAFLD: a high-risk cohort with definite therapeutic potential, file e1dcb336-7cd3-7715-e053-1705fe0a6cc9
|
7
|
|
Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO), file e1dcb33a-2e6a-7715-e053-1705fe0a6cc9
|
7
|
|
Diabetes in migrants and ethnic minorities in a changing World, file e1dcb32e-bc76-7715-e053-1705fe0a6cc9
|
6
|
|
3D bone architecture in weight-bearing combined to pressure measurements in the diabetic foot, file e1dcb334-7057-7715-e053-1705fe0a6cc9
|
6
|
|
Reduced quality of life of patients with hepatocellular carcinoma, file e1dcb336-0748-7715-e053-1705fe0a6cc9
|
6
|
|
Non-alcoholic fatty liver disease: A patient guideline, file e1dcb338-937f-7715-e053-1705fe0a6cc9
|
6
|
|
The treatment of diabetes in advanced liver disease: change of a paradigm, file a2825110-7f6e-4daf-ae3c-72c995641d4a
|
5
|
|
Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome, file e1dcb32d-1385-7715-e053-1705fe0a6cc9
|
5
|
|
Adipose tissue-associated cancer risk: Is it the fat around the liver, or the fat inside the liver?, file e1dcb333-6f8d-7715-e053-1705fe0a6cc9
|
4
|
|
Lifestyle changes for the treatment of nonalcoholic fatty liver disease-a 2015-19 update, file e1dcb336-2a20-7715-e053-1705fe0a6cc9
|
4
|
|
NAFLD and adverse hepatic and extra-hepatic outcomes, file e1dcb32c-03cf-7715-e053-1705fe0a6cc9
|
3
|
|
null, file e1dcb330-0a4c-7715-e053-1705fe0a6cc9
|
3
|
|
The effect of lutein on eye and extra-eye health, file e1dcb331-8ba6-7715-e053-1705fe0a6cc9
|
3
|
|
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030, file e1dcb331-e9d5-7715-e053-1705fe0a6cc9
|
3
|
|
Nonalcoholic fatty liver disease: Disease and comorbidity--effects on quality of life, file e1dcb32b-e5cd-7715-e053-1705fe0a6cc9
|
2
|
|
Hyperhomocysteinaemia and vascular disease in liver patients, file e1dcb32c-1666-7715-e053-1705fe0a6cc9
|
2
|
|
The presence of white matter lesions is associated with the fibrosis severity of nonalcoholic fatty liver disease, file e1dcb32e-c6a8-7715-e053-1705fe0a6cc9
|
2
|
|
NASH: A glance at the landscape of pharmacological treatment, file e1dcb32e-c87d-7715-e053-1705fe0a6cc9
|
2
|
|
Estimating the risk of severe hypoglycemic event related to glucose-lowering treatment among Italian patients with diabetes: The HYPOTHESIS database, file e1dcb330-ba3e-7715-e053-1705fe0a6cc9
|
2
|
|
Efficacy and safety of lixisenatide in patients with type 2 diabetes and renal impairment, file e1dcb330-ed1a-7715-e053-1705fe0a6cc9
|
2
|
|
The Economic Burden of Insulin-Related Hypoglycemia in Adults with Diabetes: An Analysis from the Perspective of the Italian Healthcare System, file e1dcb331-8b98-7715-e053-1705fe0a6cc9
|
2
|
|
Reactive hyperemia index (RHI) and cognitive performance indexes are associated with histologic markers of liver disease in subjects with non-alcoholic fatty liver disease (NAFLD): A case control study, file e1dcb331-aa91-7715-e053-1705fe0a6cc9
|
2
|
|
Non-alcoholic fatty liver disease: Not time for an obituary just yet!, file e1dcb338-07ee-7715-e053-1705fe0a6cc9
|
2
|
|
European ‘NAFLD Preparedness Index’ — Is Europe ready to meet the challenge of fatty liver disease?, file e1dcb338-6524-7715-e053-1705fe0a6cc9
|
2
|
|
Clinical burden of diabetes in Italy in 2018: A look at a systemic disease from the ARNO Diabetes Observatory, file f4a49fec-41f7-4a57-aebe-c52b16ed0d2f
|
2
|
|
Association between Albumin Alterations and Renal Function in Patients with Type 2 Diabetes Mellitus, file b6aae05c-04d2-4e30-9530-9f2686878c1d
|
1
|
|
Assessing the association of pioglitazone use and bladder cancer
through drug adverse event reporting, file e1dcb32b-b67d-7715-e053-1705fe0a6cc9
|
1
|
|
Metabolic Syndrome and NASH, file e1dcb32b-d701-7715-e053-1705fe0a6cc9
|
1
|
|
null, file e1dcb32c-09d6-7715-e053-1705fe0a6cc9
|
1
|
|
A randomized, controlled trial of 3.0 mg of liraglutide in weight management, file e1dcb32d-0fa6-7715-e053-1705fe0a6cc9
|
1
|
|
When the journey from obesity to cirrhosis takes an early start, file e1dcb32e-c6ab-7715-e053-1705fe0a6cc9
|
1
|
|
NAFLD incidence and remission: only a matter of weight gain and weight loss?, file e1dcb32f-3c17-7715-e053-1705fe0a6cc9
|
1
|
|
Evidence-based medicine and the problem of healthy volunteers, file e1dcb330-fcd0-7715-e053-1705fe0a6cc9
|
1
|
|
Adverse events with sodium-glucose co-transporter-2 inhibitors: A global analysis of international spontaneous reporting systems, file e1dcb331-0a5f-7715-e053-1705fe0a6cc9
|
1
|
|
Searching food during the night: the role of video-polysomnography in the characterization of the night eating syndrome, file e1dcb333-af00-7715-e053-1705fe0a6cc9
|
1
|
|
Effect of short term intensive lifestyle intervention on hepatic steatosis indexes in adults with obesity and/or type 2 diabetes, file e1dcb334-199d-7715-e053-1705fe0a6cc9
|
1
|
|
Effects of systemic prostaglandin E1 on splanchnic and peripheral haemodynamics in control subjects and in patients with cirrhosis, file e1dcb336-09a8-7715-e053-1705fe0a6cc9
|
1
|
|
Signal of potentially protective drug–drug interactions from spontaneous reporting systems: proceed with caution, file e1dcb336-d3cd-7715-e053-1705fe0a6cc9
|
1
|
|
The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality, file e1dcb338-ba93-7715-e053-1705fe0a6cc9
|
1
|
|
Emotional intelligence, emotion regulation and affectivity in adults seeking treatment for obesity., file e1dcb339-0e49-7715-e053-1705fe0a6cc9
|
1
|
|
Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO), file e1dcb33a-36fa-7715-e053-1705fe0a6cc9
|
1
|
| Totale |
2.974 |